Annual report pursuant to Section 13 and 15(d)

8. Common Stock and Equity Payable (Details)

v3.20.1
8. Common Stock and Equity Payable (Details) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
Nov. 06, 2018
Feb. 07, 2018
Jul. 31, 2019
Oct. 19, 2018
Aug. 29, 2018
Jun. 30, 2018
Feb. 23, 2018
Sep. 30, 2019
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Shares issued 8,426 12,500   84,679 24,792 1,047,583 1,808   2,018,125    
Shares Issued, Price Per Share   $ 0.78   $ 1.20 $ 0.48            
Issuance of common stock for debt conversion, Shares                     2,582,916
Proceeds from issuance of common stock, gross   $ 9,595     $ 11,875            
Common Stock For Cashless Transaction For Warrant Exercise 25,000           25,000        
Common stock issued for warrant exercise       101,615         2,018,125    
Offering Price     $ 1.00     $ 1.00          
Sale of common stock               5,775,000   2,800,000  
Proceeds from sale of common stock               $ 5,775,000      
Loss on conversion           $ 41,902       $ 232,462  
Stock-based compensation expense                     $ 260,000
Exercise Price     $ 1.25                
Equity payable                   100,862 $ 100,862
Principal                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Face amount           1,000,000       2,500,000  
Accrued interest                      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]                      
Face amount           $ 47,583       $ 82,916